Syros Pharmaceuticals logo

Syros Pharmaceuticals Share Price Today

(NASDAQ: SYRS)

Syros Pharmaceuticals share price is $0.09 & ₹7.84 as on 6 Mar 2025, 2.30 'hrs' IST

$0.09

Market is closed - opens 8 PM, 06 Mar 2025

View live Syros Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Syros Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Syros Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Syros Pharmaceuticals share price movements

  • Today's Low: $0.08
    Today's High: $0.09

    Day's Volatility :14.33%

  • 52 Weeks Low: $0.07
    52 Weeks High: $7.27

    52 Weeks Volatility :99.1%

Syros Pharmaceuticals (SYRS) Returns

PeriodSyros Pharmaceuticals IncRussel 2000Index (Russel 2000)
3 Months
-63.58%
0.0%
0.0%
6 Months
-94.37%
0.0%
0.0%
1 Year
-98.79%
0.0%
0.0%
3 Years
-99.16%
-11.6%
-11.6%

Syros Pharmaceuticals (SYRS) Key Statistics

in dollars & INR

Previous Close
$0.085
Open
$0.085
Today's High
$0.09
Today's Low
$0.0771
Market Capitalization
$2.3M
Today's Volume
$13.8M
52 Week High
$7.27
52 Week Low
$0.0653
Revenue TTM
$386.0K
EBITDA
$-110.2M
Earnings Per Share (EPS)
$-3.22
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-776.96%

How to invest in Syros Pharmaceuticals Stock (SYRS) from India?

It is very easy for Indian residents to invest directly in Syros Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Syros Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Syros Pharmaceuticals or SYRS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Syros Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Syros Pharmaceuticals shares which would translate to 9.674 fractional shares of Syros Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Syros Pharmaceuticals, in just a few clicks!

Returns in Syros Pharmaceuticals (SYRS) for Indian investors in Rupees

The Syros Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Syros Pharmaceuticals investment value today

Current value as on today

₹6,327

Returns

₹93,673

(-93.67%)

Returns from Syros Pharmaceuticals Stock

₹98,738 (-98.74%)

Dollar Returns

₹5,065 (+5.06%)

Indian investors sentiment towards Syros Pharmaceuticals (SYRS)

32.84%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Investment in Syros Pharmaceuticals Shares from India has grown by 32.84% over the past 30 days, indicating increased transactional activity.

-36%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Syros Pharmaceuticals Stock from India on INDmoney has decreased by -36% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Syros Pharmaceuticals

  • Bain Capital Life Sciences Investors, LLC

    10.25%

  • BlackRock Inc

    1.03%

  • Vanguard Group Inc

    1.00%

  • Omega Fund Management LLC

    0.94%

  • Geode Capital Management, LLC

    0.73%

  • Affinity Asset Advisors, LLC

    0.56%

Analyst Recommendation on Syros Pharmaceuticals

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Syros Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
10
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Syros Pharmaceuticals Stock (SYRS)

What analysts predicted

Upside of 9622.22%

Target:

$8.75

Current:

$0.09

Insights on Syros Pharmaceuticals Stock (Ticker Symbol: SYRS)

  • Price Movement

    In the last 7 days, SYRS stock has moved down by -40.4%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 3.76M → 386.0K (in $), with an average decrease of 89.7% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -23.32M → -6.39M (in $), with an average increase of 264.7% per quarter
  • SYRS vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 165.3%
  • SYRS vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 150.8%
  • Price to Sales

    ForSYRS every $1 of sales, investors are willing to pay $8.6, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Syros Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Syros Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Syros Pharmaceuticals (SYRS) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Syros Pharmaceuticals Inc logo
-49.05%
-94.37%
-98.79%
-99.16%
-99.85%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Syros Pharmaceuticals Inc logo
6.88
NA
0.0
0.0
-7.77
-0.6
NA
-0.41
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Syros Pharmaceuticals Inc logo
Buy
$2.3M
-99.85%
6.88
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Syros Pharmaceuticals

Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hematologic malignancies. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically defined subset of patients with myelodysplastic syndrome and Phase II clinical trial for patients with acute myeloid leukemia; SY-2101, a novel oral form of arsenic trioxide for treating patients with acute promyelocytic leukemia; and SY-5609, a cyclin-dependent kinase 7 inhibitor, which is in a Phase I clinical trial in patients with select advanced solid tumors. The company was formerly known as LS22, Inc. and changed its name to Syros Pharmaceuticals, Inc. in August 2012. Syros Pharmaceuticals, Inc. was incorporated in 2011 and is headquartered in Cambridge, Massachusetts.
Organization
Syros Pharmaceuticals
Employees
68
CEO
Dr. James E. Bradner M.D.
Industry
Health Technology

Management People of Syros Pharmaceuticals

NameTitle
Dr. James E. Bradner M.D.
Founder
Dr. Nathanael S. Gray Ph.D.
Scientific Founder & Member of Scientific Advisory Board

Important FAQs about investing in SYRS Stock from India :

What is Syros Pharmaceuticals share price today?

Syros Pharmaceuticals share price today stands at $0.09, Open: $0.09 ; Previous Close: $0.09 ; High: $0.09 ; Low: $0.08 ; 52 Week High: $7.27 ; 52 Week Low: $0.07.

The stock opens at $0.09, after a previous close of $0.09. The stock reached a daily high of $0.09 and a low of $0.08, with a 52-week high of $7.27 and a 52-week low of $0.07.

Can Indians buy Syros Pharmaceuticals shares?

Yes, Indians can invest in the Syros Pharmaceuticals (SYRS) from India.

With INDmoney, you can buy Syros Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Syros Pharmaceuticals at zero transaction cost.

How can I buy Syros Pharmaceuticals shares from India?

It is very easy to buy Syros Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Syros Pharmaceuticals (SYRS) be purchased?

Yes, you can buy fractional shares of Syros Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Syros Pharmaceuticals stocks?

To start investing in Syros Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Syros Pharmaceuticals Stock (SYRS)?

Today’s highest price of Syros Pharmaceuticals (SYRS) is $0.09.

Today’s lowest price of Syros Pharmaceuticals (SYRS) is $0.08.

What is today's market capitalisation of Syros Pharmaceuticals?

Today's market capitalisation of Syros Pharmaceuticals SYRS is 2.3M

What is the 52 Week High and Low Range of Syros Pharmaceuticals Stock (SYRS)?

  • 52 Week High

    $7.27

  • 52 Week Low

    $0.07

What are the historical returns of Syros Pharmaceuticals (SYRS)?

  • 1 Month Returns

    -49.05%

  • 3 Months Returns

    -94.37%

  • 1 Year Returns

    -98.79%

  • 5 Years Returns

    -99.85%

Who is the Chief Executive Officer (CEO) of Syros Pharmaceuticals ?

Dr. James E. Bradner M.D. is the current Chief Executive Officer (CEO) of Syros Pharmaceuticals.